Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood Doses
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- The Pediatric infectious disease journal
- Publicado em
- 5 mar 2025
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood Doses
Sonia M McAlister, Anita H J van den Biggelaar, Matthew N Cooper, Ruth Thornton, Peter Richmond, Helen S Marshall, Terry Nolan, Peter McIntyre, Nicholas Wood
Descritores MeSH
- Antibodies, Bacterial
- Antibody Formation
- Whooping Cough
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Humans
- Immunoglobulin G
- Immunization Schedule
- Immunization, Secondary
- Infant
- Infant, Newborn
Veja também
Estudos relacionados
- Immune impacts of infant whole-cell and acellular pertussis vaccination on co-administered vaccines
- A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers
- An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England
- Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial